Lisa A. Kuttner-Kondo, Ph.D.
Affiliations: | 2001 | Case Western Reserve University School of Medicine, Cleveland, OH, United States |
Area:
Immunology, Molecular BiologyGoogle:
"Lisa Kuttner-Kondo"Parents
Sign in to add mentor| M Edward Medof | grad student | 2001 | Case Western Medical School | |
| (Structure/function and evolutionary studies of decay -accelerating factor leading to characterization of active sites in the molecule.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kuttner-Kondo L, Hourcade DE, Anderson VE, et al. (2007) Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases. The Journal of Biological Chemistry. 282: 18552-62 |
| Kuttner-Kondo L, Hourcade DE, Anderson V, et al. (2007) Structure-based mapping of DAF's active site residues that decay accelerate the C3 convertases Molecular Immunology. 44: 201 |
| Kuttner-Kondo L, Muqim N, Crabb JW, et al. (2007) Effects on factor H function of polymorphisms linked to age-related macular degeneration Molecular Immunology. 44: 201 |
| Kuttner-Kondo LA, Dybvig MP, Mitchell LM, et al. (2003) A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases. The Journal of Biological Chemistry. 278: 52386-91 |
| Hourcade DE, Mitchell L, Kuttner-Kondo LA, et al. (2002) Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb. The Journal of Biological Chemistry. 277: 1107-12 |
| Kuttner-Kondo LA, Mitchell L, Hourcade DE, et al. (2001) Characterization of the active sites in decay-accelerating factor. Journal of Immunology (Baltimore, Md. : 1950). 167: 2164-71 |
| Brodbeck WG, Kuttner-Kondo L, Mold C, et al. (2000) Structure/function studies of human decay-accelerating factor. Immunology. 101: 104-11 |
| Kuttner-Kondo L, Subramanian VB, Atkinson JP, et al. (2000) Conservation in decay accelerating factor (DAF) structure among primates. Developmental and Comparative Immunology. 24: 815-27 |
| Mitchell L, Kuttner-Kondo L, Medof M, et al. (2000) Identification of a factor B site involved in the dissociation of the AP C3 convertase by decay accelerating factor Immunopharmacology. 49: 64 |
| Kuttner-Kondo L, Mitchell L, Hourcade D, et al. (2000) Characterization of the active site in Decay-Accelerating Factor (DAF) Immunopharmacology. 49: 64 |